Skip to main content
. 2019 Feb 14;34(2):e1166–e1178. doi: 10.1002/hpm.2752

Table 4.

Drug combination costs

Drug Name Observation Mean US$ (95% CI) Median US$ (IQR)
Enalapril 11 37.6 (18.8‐56.3) 47.1 (10.6‐56.5)
Hydrochlorothiazide 19 25.9 (14.2‐37.6) 21.2 (4.7‐47.1)
Nifedipine 51 31.7 (20.0‐43.5) 13.5 (3.9‐52.9)
Enalapril + hydrochlorothiazide 24 43.7 (29.2‐58.3) 40.6 (18.2‐61.8)
Nifedipine + enalapril 10 16.2 (6.3‐26.0) 10.6 (3.1‐22.7)
Nifedipine + hydrochlorothiazide 47 28.8 (17.6‐39.9) 17.6 (7.8‐33.5)
Nifedipine + hydrochlorothiazide + enalapril 10 36.6 (5.3‐68.0) 16.8 (7.1‐42.4)
Other combinations* 10 29.5 (15.7‐43.4) 30.6 (12.9‐38.2)

Abbreviations: CI, confidence interval; IQR, interquartile range.

Asterisk is used to describe “Other combinations” as indicated: * Aminosaliysilic Acid + Atorvastatin = 1; Aminosaliysilic Acid + Losartan = 1; Amlodipine + Aminosaliysilic Acid + Digoxin = 1; Methyldopa = 1; Amlodipine + Amitriptyline = 1; Atenolol= 1; Losartan + Atenolol = 1; Losartan = 1; Unknown = 2